A multicenter study to evaluate pain characteristics in osteogenesis imperfecta
Authors:
- Mercedes Rodriguez CelinMCMercedes Rodriguez Celin
- Members of the Brittle Bone Disorders Consortium (BBDC)M(Members of the Brittle Bone Disorders Consortium (BBDC)
- 22 October 2022
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 191 (1) , 160-172
Abstract
The objective was to describe pain characteristics and treatments used in individuals with varying severity of osteogenesis imperfecta (OI) and investigate pain‐associated variables. This work was derived from a multicenter, longitudinal, observational, natural history study of OI conducted at 12 clinical sites of the NIH Rare Diseases Clinical Research Network's Brittle Bone Disorders Consortium. Children and adults with a clinical, biochemical, or molecular diagnosis of OI were enrolled in the study. We did a cross‐sectional analysis of chronic pain prevalence, characteristics, and treatments used for pain relief and longitudinal analysis to find the predictors of chronic pain. We included 861 individuals with OI, in 41.8% chronic pain was present, with similar frequency across OI types. Back pain was the most frequent location. Nonsteroidal anti‐inflammatory drugs followed by bisphosphonates were the most common treatment used. Participants with chronic pain missed more days from school or work/year and performed worse in all mobility metrics than participants without chronic pain. The variables more significantly associated with chronic pain were age, sex, positive history of rodding surgery, scoliosis, other medical problems, assistive devices, lower standardized height, and higher body mass index. The predictors of chronic pain for all OI types were age, use of a wheelchair, and the number of fractures/year. Chronic pain is prevalent in OI across all OI types, affects mobility, and interferes with participation. Multiple covariates were associated with chronic pain.Keywords
Funding Information
- Banting and Best Diabetes Centre, University of Toronto
- National Institute on Disability, Independent Living, and Rehabilitation Research (90ARHF0006‐01)
- Shriners Hospitals for Children
- National Center for Advancing Translational Sciences
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- National Institute of Dental and Craniofacial Research
- National Institutes of Health
This publication has 48 references indexed in Scilit:
- A cross‐sectional multicenter study of osteogenesis imperfecta in North America – results from the linked clinical research centersClinical Genetics, 2014
- Osteogenesis imperfecta: Clinical diagnosis, nomenclature and severity assessmentAmerican Journal of Medical Genetics Part A, 2014
- Quality of life in children and adolescents with Osteogenesis Imperfecta: a qualitative interview based studyHealth and Quality of Life Outcomes, 2014
- Chronic pain epidemiology and its clinical relevanceBritish Journal of Anaesthesia, 2013
- The Prevalence of Chronic Pain in United States Adults: Results of an Internet-Based SurveyThe Journal of Pain, 2010
- Osteogénesis imperfecta. Evaluación clínica, funcional y multidisciplinaria de 65 pacientesAnales de Pediatría, 2010
- Measurement of self-reported pain intensity in children and adolescentsJournal of Psychosomatic Research, 2010
- Ankle Strength and Functional Limitations in Children and Adolescents With Type I Osteogenesis ImperfectaPediatric Physical Therapy, 2010
- Core Outcome Domains and Measures for Pediatric Acute and Chronic/Recurrent Pain Clinical Trials: PedIMMPACT RecommendationsThe Journal of Pain, 2008
- Fracture and non‐fracture pain in children with osteogenesis imperfectaActa Paediatrica, 2005